Gilead Sciences Secures European Commission Marketing Authorization For Trodelvy

FOSTER CITY (dpa-AFX) – Tuesday, Gilead Sciences, Inc. (GILD) announced that the European Commission has granted marketing authorization for Trodelvy, also known as sacituzumab govitecan-hziy, as …